A Scottish ‘Yes’ Can Boost ARM Holdings Plc, AstraZeneca plc, BHP Billiton plc, Diageo plc & GlaxoSmithKline plc

ARM Holdings Plc (LON:ARM), AstraZeneca plc (LON:AZN), BHP Billiton plc (LON:BLT), Diageo plc (LON:DGE) and GlaxoSmithKline plc (LON:GSK) shareholders may have cause to celebrate Scottish independence

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Pound CoinsOne big loser in the Scottish referendum debate is the pound. Sterling has fallen to a 10-month low as investors pull their money out of Britain ahead of next week’s vote.

It could fall another 15% next week if the Scots exit the union, according to Japan’s biggest bank, Nomura.

That would be bad news for the pound, but it could be good news for ARM Holdings (LSE: ARM), AstraZeneca (LSE: AZN), BHP Billiton (LSE: BLT), Diageo (LSE: DGE) and GlaxoSmithKline (LSE: GSK).

All five FTSE 100 favourites generate the vast majority of their earnings overseas. The weaker the pound, the more those earnings are worth once converted into their home currency.

A Yes vote could hit sink share prices, but these five stocks have more ballast than most.

First Do No ARM

ARM Holdings generates 95% of its earnings in dollars. As the pound recovered to a high of $1.71 before Scottish referendum fears took hold, its reported 17% rise in Q2 dollar earnings was worth just 9% in sterling.

Since then, the pound has dipped as low as $1.60, a drop of more than 6%. So the next set of company earnings should already show a lift from the referendum row. 

Management recently said that ARM’s forecast group dollar earnings are in line with market expectations for 2014, a Yes vote would help it beat that target. 

AstraZeneca, Pound For Pound

Global pharmaceutical company AstraZeneca earns 90% of its income outside the UK, although it reports in dollars. It also pays its dividends in dollars, and after recent sterling slippage, these are now worth more to UK investors.

AstraZeneca’s yield has fallen from nearly 6% to 3.8% over the last year, during which time the share price rose whopping 45%. But a rising US dollar should compensate for that.

With emerging market sales and group revenues rising, that’s another reason to treat AstraZeneca with respect.

BHP Billiton Digs Down

A further 15% fall in the pound would dramatically boost the income UK investors earn from companies that pay their dividends in dollars, such as mining giant BHP Billiton.

The company’s share price down almost 10% in the past month, lifting the yield from 3.4% in July to 4% today, and growing dollar strength has accelerated that return in real terms to UK-based investors. If the pound fell to $1.40, as some have mooted, then we’re talking big bucks.

The impact on reported earnings would be minimal, because BHP Billiton both generates almost all of its earnings overseas, and reports them in dollars.

Diageo Set To Go

Currency headwinds matter when you do most of your business overseas. Management at global drinks giant Diageo partly blamed adverse foreign exchange movements on its 8.5% drop in full-year revenues to $13.9bn, as stumbling emerging market currencies hit consumer demand.

The share price is up 5% in the last month, and although there is more to that than sterling’s fall, revenues will certainly feel the benefit if a Yes vote scuppers sterling.

Diageo’s dividend is priced in pounds, however, so don’t expect any good news there. Which is a shame, given its disappointing 2.8% yield, well below the FTSE 100 average of 3.43%.

So-So Glaxo

Like AstraZeneca, GlaxoSmithKline earns around 90% of its profits in foreign fields. At the end of the second quarter, with the pound standing strong at $1.71, management had cause to complain about currency headwinds.

These made bad figures even worse. Q2 turnover fell 4% at comparative exchange rates, but that multiplied to 13% at actual exchange rates.

Management will be happier today, with the pound at $1.62. 

Glaxo’s dividend is paid in sterling, so no FX uplift there. Still, at 5.43%, who’s complaining?

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Ice cube tray filled with ice cubes and three loose ice cubes against dark wood.
Investing Articles

Just released: our 3 top income-focused stocks to buy before April [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Investing Articles

Is this the best chance to buy cheap FTSE 100 shares in a generation?

I want to buy shares when they're cheap, and sell... never, just keep taking the dividends. And the FTSE 100…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Could NatWest shares be 2024’s number one buy for passive income?

For those of us looking to earn some long-term passive income, how does NatWest's 7% dividend yield sound? It sounds…

Read more »

Investing Articles

£12K in savings? Here’s how I could turn that into £13K annual passive income

This Fool explains how investing a lump sum can help her build a passive income stream to enjoy in her…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s why Rolls-Royce shares are now set to fly over the £4 mark

Once again, Rolls-Royce shares are crushing the FTSE 100. Should I add to my holding of this stock at the…

Read more »

Investing Articles

1 under the radar FTSE 100 AI stock investors should consider buying

Our writer explains why this FTSE 100 pick could be a shrewd investment with its established experience of using AI…

Read more »

Investing Articles

Does the beaten-down Diageo share price make it a no-brainer buy?

Harvey Jones spent years waiting for the Diageo share price to look like good value, before finally buying it in…

Read more »

One English pound placed on a graph to represent an economic down turn
Investing Articles

8%+ yields! Should I buy these FTSE 100 income shares this month?

Christopher Ruane weighs some pros and cons of two FTSE 100 shares, both of which have a dividend yield over…

Read more »